Exploring the link between D-dimer and major adverse cardiovascular events in smokers with type 2 diabetes mellitus
نویسندگان
doi
10.48309/jmpcr.2026.530850.1745چکیده
Type 2 Diabetes Mellitus (T2DM) poses a uniquely elevated cardiovascular risk when combined with smoking due to synergistic effects of chronic hyperglycemia and endothelial dysfunction. With a global T2DM prevalence of 589 million (projected to reach 853 million by 2050) and cardiovascular disease (CVD) accounting for 32.2% of comorbidities, identifying reliable biomarkers for major adverse cardiovascular events (MACE) is crucial. This study aimed to assess the predictive value of D-dimer for MACE in smokers with T2DM, examine its association with glycemic control, and evaluate its potential role in early cardiovascular risk assessment. A retrospective study analyzed medical records of 40 smokers and 40 non-smokers with T2DM using SPSS. Non-parametric tests were applied due to non-normal distributions (Shapiro-Wilk test: D-dimer, p < 0.001; HbA1c, p < 0.001). A significant negative Spearman correlation was found between age and stroke in smokers (r = -0.429, p = 0.006). However, logistic regression revealed no statistically significant association between D-dimer, cholesterol, HbA1c, and MACE (χ² = 7.752, p = 0.170). The Hosmer-Lemeshow test indicated acceptable model fit (χ² = 13.821, p = 0.087), but elevated D-dimer did not reliably predict MACE in this cohort. While D-dimer remains a biomarker of interest, this study did not establish its independent predictive value for MACE in smokers with T2DM. Further large-scale, prospective studies are needed to clarify its clinical utility in this high-risk population.